Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
4.035
+0.045 (1.13%)
Nov 21, 2024, 1:24 PM EST - Market open
Geron Employees
Geron had 141 employees as of December 31, 2023. The number of employees increased by 34 or 31.78% compared to the previous year.
Employees
141
Change (1Y)
34
Growth (1Y)
31.78%
Revenue / Employee
$209,078
Profits / Employee
-$1,426,901
Market Cap
2.44B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
iRhythm Technologies | 2,000 |
LeMaitre Vascular | 630 |
Arrowhead Pharmaceuticals | 525 |
Keros Therapeutics | 136 |
IDEAYA Biosciences | 124 |
Protagonist Therapeutics | 112 |
CG Oncology | 61 |
Longboard Pharmaceuticals | 50 |
GERN News
- 9 days ago - Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development - Business Wire
- 10 days ago - Geron to Participate in the Stifel 2024 Healthcare Conference - Business Wire
- 14 days ago - Geron: A Post Earnings And Funding Announcement Assessment - Seeking Alpha
- 14 days ago - Geron Corporation (GERN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors - Business Wire
- 14 days ago - Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 16 days ago - Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies - Business Wire
- 4 weeks ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire